Skip to content
healthcare.dev
Get a free key

Fluticasone propionate and Salmeterol

NDC 69097-661, Fluticasone propionate and Salmeterol, powder, from Cipla USA Inc..

Product NDC
69097-661
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
POWDER
Route
RESPIRATORY (INHALATION)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213087
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-661 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FLUTICASONE PROPIONATE250 ug/1
  • SALMETEROL XINAFOATE50 ug/1

Pharmacologic classes

Adrenergic beta2-Agonists [MoA]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; beta2-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
69097-661-03690970661031 INHALER in 1 CARTON (69097-661-03) / 60 POWDER in 1 INHALER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1349a04c-2024-42b9-b81d-a7d995716ade

Use it

Look up 69097-661 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-661 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-661. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.